Donna Ryan
Internal Medicine · Baton Rouge, LANPI 1801197363
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Novo Nordisk at 43.5% of the total. Among internal medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 789 payments — averaging $1256.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$431K
- Lilly USA, LLC$174K
- Novo Nordisk AS$101K
- Eli Lilly$79K
- Boehringer Ingelheim$64K
- Bausch Health US, LLC$29K
- plus $114K from 17 others
Across 48 payments — averaging $2075.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$89K
- Amgen$11K
What the payments were for
- Consulting fees$411,09541%
- Speaking & faculty fees$395,33840%
- Grants$5,7501%
- Travel & lodging$162,33116%
- Food & beverage$16,6422%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 377 | $431,242 |
| Lilly USA, LLC | 152 | $173,631 |
| Novo Nordisk AS | 39 | $101,084 |
| Eli Lilly | 65 | $78,664 |
| Boehringer Ingelheim | 53 | $63,538 |
| Bausch Health US, LLC | 3 | $28,934 |
| Amgen | 14 | $26,852 |
| Regeneron | 33 | $21,535 |
| Sanofi-aventis U.S. LLC | 6 | $21,222 |
| Currax Pharmaceuticals LLC | 16 | $17,364 |
| F. Hoffmann-la Roche AG | 6 | $5,969 |
| Astrazeneca UK Limited | 3 | $5,100 |
| Genentech USA, Inc. | 2 | $4,873 |
| Pfizer | 2 | $3,570 |
| Janssen Global Services, LLC | 5 | $3,349 |
| Rhythm Pharmaceuticals, Inc. | 4 | $1,806 |
| Boehringer Ingelheim International GmbH | 1 | $900 |
| Genentech, Inc. | 1 | $638 |
| Intuitive Surgical | 1 | $500 |
| Zealand Pharma US, Inc. | 1 | $189 |
| Janssen Scientific Affairs, LLC | 2 | $123 |
| Lifescan, Inc. | 2 | $85 |
| Corcept Therapeutics | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Saxenda$161,018
- ZEPBOUND$152,901
- Wegovy$145,022
- CONTRAVE$46,167
- NO PRODUCT DISCUSSED$21,115
- Ozempic$10,730
- MOUNJARO$790
- Da Vinci Surgical System$500
- ZEGALOGUE$189
How this compares
$991,214 in reported general payments places this provider in the 95th percentile of 1,528 internal medicine providers in Louisiana.
Other internal medicine in Baton Rouge
- John SchwabBaton Rouge$122K
- Barret MurphyBaton Rouge$43K
- Brian GremillionBaton Rouge$27K
- Bradley MeekBaton Rouge$20K
- Leo BlaizeBaton Rouge$17K
- Michael HymbaughBaton Rouge$16K
- Kyle ChampagneBaton Rouge$16K
- Charles HalliburtonBaton Rouge$16K
- Hartman BruntBaton Rouge$15K
- Lauren BarfieldBaton Rouge$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.